Crossmark

In-vitro osteoblast proliferation and in-vivo anti-osteoporotic activity of Bombax ceiba with quantification of Lupeol, gallic acid and β-sitosterol by HPTLC and HPLC

Crossref DOI link: https://doi.org/10.1186/s12906-018-2299-1

Published Online: 2018-08-07

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chauhan, Shashi

Sharma, Aditi

Upadhyay, Navneet Kumar

Singh, Gajender

Lal, Uma Ranjan

Goyal, Rohit http://orcid.org/0000-0001-6307-0055
License Information

Text and Data Mining valid from 2018-08-07
More Information

Article History

Received: 28 April 2018

Accepted: 27 July 2018

First Online: 7 August 2018

Ethics approval and consent to participate

: The presented research work involves the use of small experimental animals and the experimental protocol was duly approved from Institutional Animal Ethics Committee, Shoolini University, Solan, HP, India vide protocol no. IAEC/SU-PHARM/13/017, and was conducted as per the guidelines of Committee for the purpose of control and supervision of experiments on animals (CPCSEA) under Ministry of Environment, Forest & Climate Change (under Prevention of Cruelty Act, 1960), Govt. of India, New Delhi, India. The study involves the use of small experimental animals which were procured from Animal house facility of the host institution, Shoolini University, Solan, HP, India and the experiments adherence to a high standard (best practice) of veterinary care.

: Not applicable.

: The author R. Goyal is a member of BMC CAM editorial board and other authors declares that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below